About XOPENEX HFA® (levalbuterol tartrate) Inhalation Aerosol

XOPENEX HFA® (levalbuterol tartrate) Inhalation Aerosol (pronounced zō-pen-eks) is a quick-relief medicine that is used to treat or prevent the narrowing of airways (bronchospasm) caused by asthma and chronic obstructive pulmonary disease (COPD) with reversible obstructed airway disease.

 

Possible side effects for XOPENEX HFA Inhalation Aerosol

In patients aged 4-11 years, the most common side effects for XOPENEX HFA were vomiting, accidental injury, irritation of the throat, and bronchitis.

In patients aged 12 years and older, the most common side effects for XOPENEX HFA were asthma, irritation of the nose and/or throat, pain, and dizziness.

These are not all the possible side effects with XOPENEX HFA. For more information, talk to your healthcare professional and see the full Prescribing Information for XOPENEX HFA Inhalation Aerosol.

Understanding Asthma

In most patients, asthma is a long-term disease of the airways. Some people develop asthma because they have allergies. Others develop asthma for unclear reasons.

Focus On:

Healthcare Professionals

An information and resource center.

 

XOPENEX HFA® (levalbuterol tartrate) Inhalation Aerosol is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstructive airway disease.

 

 
 

You are now leaving the XOPENEX HFA® (levalbuterol tartrate) Inhalation Aerosol website. Sunovion is not responsible for the information contained in any of the linked sites.